Skip to main content
Clinical Trials/JPRN-UMIN000005507
JPRN-UMIN000005507
Completed
未知

Evaluation on an introduction method of fentanyl patch by using short-acting opioid for cancer pain management in the outpatient setting. - Evaluation on an introduction method of fentanyl patch by using short-acting opioid for cancer pain management in the outpatient setting.(Miyagi-HBPCOG 008)

Tohoku University Graduate School of Medicine Division of Integrated Surgery and Oncology0 sites30 target enrollmentApril 26, 2011
ConditionsCancer Pain

Overview

Phase
未知
Intervention
Not specified
Conditions
Cancer Pain
Sponsor
Tohoku University Graduate School of Medicine Division of Integrated Surgery and Oncology
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 26, 2011
End Date
March 31, 2014
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tohoku University Graduate School of Medicine Division of Integrated Surgery and Oncology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with hypersensitivity to opioid Patients with medical history of opiod addiction Patients considered necessary for titration inpatient setting Patients with respiratory dysfunctions such as chronic lung disease Patients with asthma Patients with serious heart dysfunction Patients with serious hepatic or renal dysfunction Patients with intracranial hypertension and disturbed consciousness Patients with skin disease such as eczema and atopy at the attached site Patients with 40 degree or more fever Homeostatically Pregnant patients and patients who may possibly be pregnant. Patients treated with opioid antagonists such as pentazocine and buprenorphine within 2 days prior to fentanyl patch attachment. Patients under the age of 20 Patients considered as inappropriate for study by investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials